70 results
Page 3 of 4
8-K
EX-99.1
mkt2gct
2 Apr 20
Moleculin Announces Additional Positive Safety Data in EU AML Trial
7:30am
8-K
EX-99.1
aynioga
19 Mar 20
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
1rvg x8mdrnkkkje
5 Feb 20
Moleculin to Seek Accelerated FDA Approval and Plans for Pivotal Phase 2 AML Trial
7:30am
8-K
EX-99.1
4ss7qv4u wl
3 Feb 20
Moleculin Announces Successful Completion of US Phase 1 AML Trial of Annamycin
7:32am
8-K
EX-99.1
gwpk2pn ei4
4 Dec 19
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
7:31am
8-K
EX-99.1
4cxbnx u0bct6mf7
12 Nov 19
Results of Operations and Financial Condition
6:33am
8-K
EX-99.1
maw3gw190e
16 Aug 19
Results of Operations and Financial Condition
5:18pm
8-K
EX-99.1
o8kpulcr5hv14soz4
18 Jul 19
Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort
4:02pm
8-K
EX-99.1
1t8sg zmjipg
14 May 19
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
j10b3z0z7
7 May 19
Regulation FD Disclosure
4:34pm
8-K
EX-99.1
xg5r1sg
26 Mar 19
Moleculin Announces Positive Interim Results in First Cohort of
7:31am
8-K
EX-99.1
bq486h oyzi0okrcvtup
14 Mar 19
Moleculin Announces First Patients Treated in European Annamycin Clinical Trial
4:20pm
8-K
EX-99.1
efnnli6myppsx3xm1 b3
21 Feb 19
Results of Operations and Financial Condition
4:32pm
8-K
EX-99.1
17nqcitz1c1d0r6c
7 Feb 19
Moleculin Announces Approval for Third Drug to Commence Clinical Trials
4:01pm